Market access ensures that clinicians have the right to use the most innovative solutions available, which allows them to deliver the very best care to their patients.
As an independent organisation, Interface Clinical Services (ICS) can assist with all aspects of developing and delivering a successful market access strategy. From assisting with operational and resource capabilities, to providing compliance, coding and regulatory support.
ICS acts as an interface to deliver an aligned approach that enables patients to receive the right solutions, delivered within the right environment and the right health economy, at the right time. Whether it be medication, treatment or educational materials, ICS ensures that the focus fully remains on the patient and providing them access to the services and support that they need.
The market access process ensures that national and local policy makers have considered the implications any new products or services will have on the healthcare economy and that the value to both the NHS and patient experience has been demonstrated. ICS can help industry partners effectively convey this value, so patients receive the access they need without delay.